Glympse Bio Leadership

Gabe trained as a bioengineer at UC Berkeley, Caltech and MIT, and currently is a Principal Investigator at the Lab for Synthetic Immunity at Georgia Tech and Emory School of Medicine. His research merges engineering approaches with discoveries in immunology to advance human health. He and his team have developed innovative technologies that shape broad applications in biomedical diagnostics and cell-based therapies, and impact frontier challenges in cancer, transplant medicine and infectious diseases. When he is not in the lab or classroom, Gabe can be found hiking, playing guitar, or at the gym training for his favorite show: American Ninja Warrior.

Caroline Loew is a Board Member at Glympse Bio Inc and President/CEO at Glympse Bio Inc and is based in Cambridge, Massachusetts. She has experience at Pharmaceutical Rsch & Mfr Amer and has worked as VP/Head:R&D Strategy & Planning at Bristol Myers Squibb SA; Vice President, Late Lifecycle Management and Loss of Exclusivity Center of Excellence at MERCK & CO., INC.; and Vice President, Customer Value and Health Technology Assessment at MERCK & CO., INC.. Caroline attended Imperial College London.

Wendy Winckler is a Chief Scientific Officer at Glympse Bio and is based in Cambridge, Massachusetts. She has worked as Exec Dir:Next Generation Diagnostics at Novartis Institutes For Biomedical Research, Inc.; Research Scientist at Dana-Farber Cancer Institute; and Director, Genetic Analysis Platform at Broad Institute. Wendy attended Harvard University between 2000 and 2005 and UCLA between 1996 and 2000.

Gabe trained as a bioengineer at UC Berkeley, Caltech and MIT, and currently is a Principal Investigator at the Lab for Synthetic Immunity at Georgia Tech and Emory School of Medicine. His research merges engineering approaches with discoveries in immunology to advance human health. He and his team have developed innovative technologies that shape broad applications in biomedical diagnostics and cell-based therapies, and impact frontier challenges in cancer, transplant medicine and infectious diseases. When he is not in the lab or classroom, Gabe can be found hiking, playing guitar, or at the gym training for his favorite show: American Ninja Warrior.

Caroline Loew is a Board Member at Glympse Bio Inc and President/CEO at Glympse Bio Inc and is based in Cambridge, Massachusetts. She has experience at Pharmaceutical Rsch & Mfr Amer and has worked as VP/Head:R&D Strategy & Planning at Bristol Myers Squibb SA; Vice President, Late Lifecycle Management and Loss of Exclusivity Center of Excellence at MERCK & CO., INC.; and Vice President, Customer Value and Health Technology Assessment at MERCK & CO., INC.. Caroline attended Imperial College London.